Connect← Return to This is the $64,000 question. . .WHY NO MED FOR NEUROPATHY?
Discussion
This is the $64,000 question. . .WHY NO MED FOR NEUROPATHY?
Neuropathy | Last Active: Sep 30 5:47pm | Replies (84)Comment receiving replies
See what I mean. I put up Winsantor and it was mainly ignored even with two posts talking about how there is nothing. Thats allright but they could have explained why or why not Winsantor is crap?
Hete is the Lancet article
https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(25)00499-2/fulltext
You can copy and paste this text into google for a pdf from St Boniface Research article:
News Release
Jan 17, 2017 — The drugs drive nerve fibre regeneration and repair in disease states such as diabetes and chemotherapy where there is otherwise irreversible
Replies to "@highdesertdweller See what I mean. I put up Winsantor and it was mainly ignored even with..."
@megidigo
The drug WinSanTor is developing is WST-057 (pinzeprine) - you might find more info searching for those terms.
Here is the latest I could find:
https://www.pfsfoundation.org/news/rushing-to-relieve-peripheral-neuropathy-winsantor-ditches-fdas-compassionate-use-program-and-goes-directly-to-the-state-with-americas-most-permissive-right-to-try-laws/
It appears the corporation has chosen to bypass the FDA required Phase III trials, so who knows what the future may be for this treatment?
Connect
@megidigo thank you for the link. I am impressed with what Pirenzepine could 'potentially' do for neuropathy and nerve repair, but it looks like it is not yet FDA approved to treat neuropathy.